Lonza Group AG
LONN
Rang in Aktien
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Aktienkurs
$763.31
Marktkapitalisierung
$53.31B
Veränderung (1 Tag)
0.87%
Veränderung (1 Jahr)
8.49%
Land
CH
Handel Lonza Group AG (LONN)
Kategorie
Healthcare
Operative Marge für Lonza Group AG (LONN)
Operative Marge zum 2026 TTM: 0.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von Lonza Group AG beträgt die aktuelle operative Marge (TTM) 0.00%. Am Ende des Jahres 2026 lag die operative Marge bei 0.00%.
Historie der operativen Marge von Lonza Group AG von 2004 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2025 | 21.16% | 44.34% |
| 2024 | 14.66% | 11.91% |
| 2023 | 13.10% | -47.09% |
| 2022 | 24.76% | 57.41% |
| 2021 | 15.73% | -24.34% |
| 2020 | 20.79% | -4.72% |
| 2019 | 21.82% | 19.76% |
| 2018 | 18.22% | 0.94% |
| 2017 | 18.05% | 20.90% |
| 2016 | 14.93% | 14.06% |
| 2015 | 13.09% | 6.86% |
| 2014 | 12.25% | 7.36% |
| 2013 | 11.41% | 33.61% |
| 2012 | 8.54% | -11.96% |
| 2011 | 9.70% | -30.52% |
| 2010 | 13.96% | 57.21% |
| 2009 | 8.88% | -40.88% |
| 2008 | 15.02% | 5.63% |
| 2007 | 14.22% | 7.97% |
| 2006 | 13.17% | 11.80% |
| 2005 | 11.78% | 21.82% |
| 2004 | 9.67% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 28.81% | - |
NL
|
|
| 31.23% | - |
BE
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.